Gene Therapy For Parkinson's Disease

This week, the first clinical trial of gene therapy for Parkinson's disease began. We'll talk about this experimental treatment.


Michael Kaplitt, M.D., Ph.D.
* Assistant Professor, Neurological Surgery Weill Cornell Medical College
* Director, Center for Stereotactic and Functional Neurosurgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York

Theodore Friedmann, M.D.
*Chair, Recombinant DNA Advisory Committee (RAC), National Institutes of Health Professor, Pediatrics
* Muriel Jeannette Whitehill Chair in Biomedical Ethics
* Director, Program in Human Gene Therapy University of California San Diego, San Diego, California

Copyright © 2003 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 2003 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.